Navigation Links
A new key to detecting deadly aortic aneurysms
Date:10/24/2007

New Haven, Conn.Yale scientists have discovered a way to use a simple blood test that may accurately detect thoracic aneurysm disease (TAA), which gives little warning and is almost always fatal if untreated.

The study, published this month in Public Library of Science (PLoS), represents the collaborative work of Yale School of Medicine, Applied Biosystems, and Celera Diagnostics.

TAAs occur in the part of the aorta that passes through the chest. They can become huge without causing symptoms. In fact, only one in 20 patients has symptoms before internal rupture occursmaking advance detection key to treatment. Once the aneurysm ruptures, a person can go into shock and die from internal bleeding. Currently detection of these aneurysms is made by relatively expensive tests such as a chest X-ray or CT scantypically when a patient is being evaluated for other conditions.

A standardized blood-based test capable of detecting individuals at risk for aneurysm disease would represent a major advance in clinical care, said John Elefteriades, M.D., section chief of cardiothoracic surgery. This study indicates we may be able to develop such a test.

In this study Elefteriades and his colleagues took blood samples from 58 persons diagnosed with TAA disease and 36 spouses who did not have the disease. Using a gene expression profiling technology, they identified a 41-gene signature in blood cells that distinguishes TAA patients from those without the disease. The gene expression signature and the prediction model were identified using a complete workflow of instruments, reagents, and software from Applied Biosystems. These signature genes were further validated using TaqMan real-time PCR assays. The accuracy rate in various analyses is 78 percent to 85 percent.

It has become increasingly evident that the immune system plays a pivotal role in the development of aortic aneurysms, Elefteriades said. We thus hypothesized that gene expression patterns in peripheral blood cells may reflect TAA disease status.

The next step, which the researchers say is underway, is validation in real-time clinical studies. The investigative team is also interested in determining if abdominal aneurysms share a similar RNA signature, and if the RNA can predict rupture or dissection of an aneurysm.


'/>"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
Source:Eurekalert

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Detecting anomalies in heart rythm
3. Detecting brain aneurysms
4. New device for detecting artery blockages
5. Detecting Colorectal Cancer
6. Associated scan for detecting ovarian cancer spread
7. Photographs An Effective Tool In Detecting Skin Cancer
8. Mammograms The Best In Detecting Breast Cancer
9. Detecting Lung Cancer Early
10. Detecting Lung Cancer In Its Initial Stages
11. A New Way Of Detecting Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... California (PRWEB) , ... January 17, 2017 , ... ... have a point of difference. Eden Activewear is a stand-out company for several ... are exclusively online and only manufacture on demand, this is called 'Agile' manufacturing ...
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful Balance announces ... company, owned and operated by Ed Stroup, was created to offer the highest ... highest level of customer service. Healthful Balance products can be purchased online through ...
(Date:1/17/2017)... Grove Village, IL (PRWEB) , ... January 17, ... ... for musicians and music enthusiasts at the National Association of Music Merchants (NAMM) ... January 19 – 22, 2017. , Etymotic’s ER•4® has long been the gold ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s ... honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD ... elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from ... primary eye care practitioners on the latest breakthroughs in the prevention, diagnosis and ... Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... LAKE, N.J. , Jan. 18, 2017 /PRNewswire/ ... Co., Ltd., announced today that it is participating ... access to non-communicable diseases (NCDs) prevention, treatment and ... Access Accelerated is the first multi-stakeholder, international ... 22 major pharmaceutical companies, including Eisai, in collaboration ...
(Date:1/18/2017)... 2017 ML Capital Group ... publish an online presentation tomorrow, January 19 th ... for 2017. Management reports that the forecast is ... performance from its existing operations, and the anticipated ... the Cannabis sector through a partnership with ...
(Date:1/18/2017)... 2017  Astellas Pharma Inc. (President and CEO: ... its participation in Access Accelerated, a global, multi-stakeholder ... prevention, diagnostics and treatment in low-income and lower-middle ... companies and in collaboration with the World Bank ... (UICC), Astellas will work towards the United Nations ...
Breaking Medicine Technology: